Banque Pictet & Cie’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.81M | Sell |
41,734
-54,521
| -57% | -$3.63M | 0.02% | 176 |
|
|
2026
Q1 | $6.04M | Sell |
96,255
-13,568
| -12% | -$945K | 0.04% | 140 |
|
|
2025
Q4 | $7.29M | Buy |
109,823
+40,411
| +58% | +$2.61M | 0.04% | 131 |
|
|
2025
Q3 | $4.67M | Sell |
69,412
-19,766
| -22% | -$1.56M | 0.03% | 159 |
|
|
2025
Q2 | $7.78M | Sell |
89,178
-14,375
| -14% | -$1.13M | 0.05% | 122 |
|
|
2025
Q1 | $7.07M | Sell |
103,553
-28,256
| -21% | -$2.31M | 0.06% | 129 |
|
|
2024
Q4 | $10.3M | Buy |
131,809
+14,419
| +12% | +$1.07M | 0.07% | 100 |
|
|
2024
Q3 | $7.87M | Sell |
117,390
-8,471
| -7% | -$696K | 0.06% | 121 |
|
|
2024
Q2 | $14.3M | Sell |
125,861
-14,372
| -10% | -$1.82M | 0.13% | 73 |
|
|
2024
Q1 | $19.5M | Sell |
140,233
-14,037
| -9% | -$1.76M | 0.18% | 59 |
|
|
2023
Q4 | $19.1M | Sell |
154,270
-19,024
| -11% | -$1.94M | 0.16% | 62 |
|
|
2023
Q3 | $16.2M | Buy |
173,294
+75,848
| +78% | +$8.55M | 0.19% | 62 |
|
|
2023
Q2 | $12.5M | Buy |
97,446
+37,141
| +62% | +$4.49M | 0.11% | 94 |
|
|
2023
Q1 | $7.01M | Sell |
60,305
-33,789
| -36% | -$3.78M | 0.07% | 131 |
|
|
2022
Q4 | $10.7M | Sell |
94,094
-5,150
| -5% | -$565K | 0.11% | 97 |
|
|
2022
Q3 | $7.99M | Sell |
99,244
-4,689
| -5% | -$397K | 0.09% | 115 |
|
|
2022
Q2 | $7.75M | Sell |
103,933
-49,243
| -32% | -$4.49M | 0.08% | 119 |
|
|
2022
Q1 | $19.6M | Buy |
153,176
+17,520
| +13% | +$1.92M | 0.15% | 78 |
|
|
2021
Q4 | $18.2M | Buy |
135,656
+91,752
| +209% | +$13.2M | 0.13% | 87 |
|
|
2021
Q3 | $6M | Sell |
43,904
-16,320
| -27% | -$2.06M | 0.06% | 134 |
|
|
2021
Q2 | $6.43M | Sell |
60,224
-3,152
| -5% | -$303K | 0.07% | 128 |
|
|
2021
Q1 | $5.69M | Buy |
63,376
+14,548
| +30% | +$1.37M | 0.07% | 136 |
|
|
2020
Q4 | $4.51M | Buy |
48,828
+37,384
| +327% | +$3.34M | 0.06% | 146 |
|
|
2020
Q3 | $1.18M | Sell |
11,444
-416
| -4% | -$43.5K | 0.02% | 211 |
|
|
2020
Q2 | $1.2M | Sell |
11,860
-3,000
| -20% | -$268K | 0.02% | 210 |
|
|
2020
Q1 | $1M | Buy |
14,860
+1,780
| +14% | +$111K | 0.02% | 216 |
|
|
2019
Q4 | $715K | Sell |
13,080
-1,460
| -10% | -$69.2K | 0.01% | 265 |
|
|
2019
Q3 | $542K | Buy |
14,540
+800
| +6% | +$31.1K | 0.01% | 262 |
|
|
2019
Q2 | $515K | Buy |
+13,740
| New | +$432K | 0.01% | 258 |
|
|
2018
Q4 | – | Sell |
-71,800
| Closed | -$2.57M | – | 331 |
|
|
2018
Q3 | $2.57M | Sell |
71,800
-5,480
| -7% | -$170K | 0.05% | 174 |
|
|
2018
Q2 | $1.83M | Sell |
77,280
-371,668
| -83% | -$7.88M | 0.04% | 197 |
|
|
2018
Q1 | $8.32M | Buy |
448,948
+75,428
| +20% | +$1.12M | 0.18% | 98 |
|
|
2017
Q4 | $5.36M | Sell |
373,520
-33,800
| -8% | -$439K | 0.11% | 133 |
|
|
2017
Q3 | $4.98M | Buy |
407,320
+287,720
| +241% | +$5.09M | 0.11% | 142 |
|
|
2017
Q2 | $2.19M | Sell |
119,600
-34,800
| -23% | -$643K | 0.05% | 201 |
|
|
2017
Q1 | $3.27M | Buy |
+154,400
| New | +$3.01M | 0.08% | 156 |
|
Other funds holding DXCM
Banque Pictet & Cie's DXCM Position: Q2 2026 in Review
Banque Pictet & Cie reduced its DexCom (DXCM) stake by 57% in Q2 2026, selling an estimated $3.63M and leaving 41,734 shares worth $2.81M. The position accounts for 0.02% of the portfolio, ranked #176.
Banque Pictet & Cie first reported a position in DXCM in Q1 2017 and has held it in 36 quarters since. The position peaked at $19.6M in Q1 2022. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Banque Pictet & Cie held 41,734 shares of DexCom worth $2.81M as of Q2 2026.
- Banque Pictet & Cie sold 54,521 DexCom shares in Q2 2026, an estimated $3.63M.
- DexCom made up 0.02% of Banque Pictet & Cie's portfolio in Q2 2026, its #176 holding.
- Banque Pictet & Cie first reported a position in DexCom in Q1 2017 and has held it in 36 quarters since.
- Banque Pictet & Cie's DexCom position peaked at $19.6M in Q1 2022.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.